Get the Stockscreener App
42.38
2.34%
0.97
Atricure Inc stock is traded at $42.38, with a volume of 525.87K.
It is up +2.34% in the last 24 hours and up +28.19% over the past month.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
See More
Previous Close:
$41.41
Open:
$41.36
24h Volume:
525.87K
Relative Volume:
1.03
Market Cap:
$2.11B
Revenue:
$499.95M
Net Income/Loss:
$-36.36M
P/E Ratio:
-55.04
EPS:
-0.77
Net Cash Flow:
$24.22M
1W Performance:
+6.32%
1M Performance:
+28.19%
6M Performance:
+31.09%
1Y Performance:
+29.25%
1-Day Range:
$41.08
$42.44
1-Week Range:
$38.92
$42.44
52-Week Range:
$28.29
$43.11
Atricure Inc Stock (ATRC) Company Profile
Name
Atricure Inc
Sector
Industry
Phone
513-755-4100
Address
7555 INNOVATION WAY, MASON, OH
Compare ATRC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
42.38 | 2.06B | 499.95M | -36.36M | 24.22M | -0.77 |
|
ISRG
Intuitive Surgical Inc
|
542.32 | 194.04B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.89 | 57.21B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.80 | 38.69B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.27 | 36.84B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
267.56 | 19.61B | 2.96B | 487.70M | 344.00M | 6.6758 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Apr-23-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-29-23 | Initiated | UBS | Buy |
| Aug-05-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Reiterated | Needham | Buy |
| Nov-06-20 | Reiterated | Needham | Buy |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-24-20 | Reiterated | Needham | Buy |
| Aug-13-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| Apr-12-19 | Initiated | JP Morgan | Overweight |
| Oct-04-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Stifel | Buy |
| Jun-18-18 | Reiterated | Needham | Buy |
| Apr-27-18 | Reiterated | Needham | Buy |
| Jan-16-18 | Reiterated | Needham | Buy |
| Nov-02-17 | Reiterated | Needham | Buy |
| Jul-28-17 | Reiterated | Needham | Buy |
| May-30-17 | Resumed | Piper Jaffray | Overweight |
| Jun-30-16 | Resumed | JMP Securities | Mkt Outperform |
| Oct-28-15 | Reiterated | Needham | Buy |
| Oct-06-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-06-15 | Reiterated | Needham | Buy |
View All
Atricure Inc Stock (ATRC) Latest News
AtriCure (ATRC) Is Up 6.3% After Dual Energy PFA–RFA First-in-Human SuccessHas The Bull Case Changed? - Yahoo Finance
Loss Report: What valuation multiples suggest for AtriCure Inc stockJuly 2025 Outlook & Fast Entry Momentum Alerts - moha.gov.vn
AtriCure treats first patients with dual PFA/RF system - MedTech Dive
ATRC Treats First Patients Using Novel Dual-Energy PFA-RFA Platform - Finviz
AtriCure reports first patients treated with dual-energy PFA, RF platform - MassDevice
AtriCure Announces the First Patients Treated with Novel Dual Energy Platform - 01net
AtriCure Reports 1st Treatments with Dual Energy RF, PFA System - Medical Product Outsourcing
AtriCure Says First Patients Treated With Dual-Energy Platform - marketscreener.com
AtriCure (ATRC) Introduces Cutting-Edge Dual Energy Platform in Initial Treatments - GuruFocus
AtriCure (Nasdaq: ATRC) Debuts Dual PFA-RF Surgical Ablation System in First Human Use - Stock Titan
AtriCure, Inc.'s (NASDAQ:ATRC) 29% Share Price Surge Not Quite Adding Up - simplywall.st
Russell Investments Group Ltd. Decreases Stake in AtriCure, Inc. $ATRC - MarketBeat
AtriCure Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
Are Medical Stocks Lagging AtriCure (ATRC) This Year? - Yahoo Finance
Hood River Capital Management LLC Has $100.31 Million Holdings in AtriCure, Inc. $ATRC - MarketBeat
Will AtriCure Inc. stock deliver strong dividend growthPortfolio Profit Report & Expert Verified Stock Movement Alerts - Newser
Why analysts remain bullish on AtriCure Inc. stock2025 Trading Recap & Consistent Growth Stock Picks - Newser
AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares? - AOL.com
AtriCure’s Ongoing Study: Implications for Cardiac Treatment and Market Performance - MSN
Geode Capital Management LLC Purchases 14,577 Shares of AtriCure, Inc. $ATRC - MarketBeat
How supply chain issues affect AtriCure Inc. stockJuly 2025 Volume & Scalable Portfolio Growth Methods - BỘ NỘI VỤ
Insider Selling: AtriCure (NASDAQ:ATRC) Director Sells 4,967 Shares of Stock - MarketBeat
Atricure Executives Make Significant Stock Sales - TipRanks
Insider Sell: Justin Noznesky Sells 5,166 Shares of AtriCure Inc (ATRC) - GuruFocus
AtriCure Executives Engage in Stock Transactions - TradingView
Atricure Insider Sold Shares Worth $376,578, According to a Recent SEC Filing - MarketScreener
Dir Wehrwein Sells 10,000 ($376.6K) Of AtriCure Inc [ATRC] - TradingView
Officer Noznesky Sells 5,166 ($192.6K) Of AtriCure Inc [ATRC] - TradingView
ATRC Form 4: Director exercises $19.95 options, trims holdings - Stock Titan
[Form 4] AtriCure, Inc. Insider Trading Activity - Stock Titan
Precision Trading with Atricure Inc. (ATRC) Risk Zones - news.stocktradersdaily.com
Officer Noznesky Files To Sell 5,166 Of AtriCure Inc [ATRC] - TradingView
Atricure Director Makes a Significant Stock Sale! - TipRanks
AtriCure director Yuen sells $107k in shares By Investing.com - Investing.com Australia
Wall Street Analysts Believe AtriCure (ATRC) Could Rally 36.3%: Here's is How to Trade - Finviz
Insider Sell: Maggie Yuen Sells 3,000 Shares of AtriCure Inc (AT - GuruFocus
AtriCure director Yuen sells $107k in shares - Investing.com
AtriCure Director Maggie Yuen Sells 3,000 Shares - TradingView
Dir Wehrwein Files To Sell 5,033 Of AtriCure Inc [ATRC] - TradingView
AtriCure, Inc. $ATRC Stake Boosted by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Dir Yuen Files To Sell 3,000 Of AtriCure Inc [ATRC] - TradingView
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year? - sharewise.com
Why AtriCure Inc. stock remains on buy lists2025 Growth vs Value & Safe Entry Momentum Stock Tips - newser.com
How AtriCure Inc. stock performs in rate cut cycles2025 EndofYear Setup & High Conviction Trade Alerts - newser.com
Atricure Inc Stock (ATRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):